CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients
- PMID: 15159291
- DOI: 10.1161/01.CIR.0000131450.66017.B3
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients
Abstract
Background: Peripheral blood expansion of an unusual CD4+ T-cell subset lacking surface CD28 has been suggested to predispose rheumatoid arthritis (RA) patients to develop more aggressive disease. However, the potential association between CD4+CD28null T cells and early atherosclerotic changes in RA has never been investigated.
Methods and results: The number of circulating CD4+CD28null cells was evaluated in 87 RA and 33 control subjects who also underwent evaluation of carotid artery intima-media thickness (IMT) and endothelial function via flow-mediated vasodilation (FMV). Patients had higher IMT and lower FMV compared with control subjects. The frequency of CD4+CD28null cells was significantly higher in patients than in control subjects. Twenty patients with persistent expansion of circulating CD4+CD28null cells had more marked increase of carotid artery IMT and stronger decrease of brachial artery FMV. Blockade of tumor necrosis factor-alpha led to a partial reappearance of the CD28 molecule on the CD4+ cell surface.
Conclusions: Circulating CD4+CD28(null) lymphocytes are increased in RA. Patients with persistent CD4+CD28null cell expansion show preclinical atherosclerotic changes, including arterial endothelial dysfunction and carotid artery wall thickening, more significantly than patients without expansion. These findings suggest a contribution of this cell subset in atheroma development in RA. Moreover, the demonstration that tumor necrosis factor-alpha blockade is able to reverse, at least in part, the CD28 deficiency on the CD4+ cell surface may be of interest for possible innovative therapeutic strategies in cardiovascular diseases.
Similar articles
-
Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease.Nephron Clin Pract. 2012;120(4):c185-93. doi: 10.1159/000338352. Epub 2012 Aug 16. Nephron Clin Pract. 2012. PMID: 22907478
-
Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina.Circulation. 2006 May 16;113(19):2272-7. doi: 10.1161/CIRCULATIONAHA.105.588533. Epub 2006 May 8. Circulation. 2006. PMID: 16682617
-
Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis.Hum Immunol. 2013 Jan;74(1):6-13. doi: 10.1016/j.humimm.2012.08.001. Epub 2012 Aug 16. Hum Immunol. 2013. PMID: 22902395
-
A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.J Nephrol. 2012 Mar-Apr;25(2):183-91. doi: 10.5301/jn.5000057. J Nephrol. 2012. PMID: 22135034 Review.
-
[Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].Ultraschall Med. 2003 Jun;24(3):162-74. doi: 10.1055/s-2003-40058. Ultraschall Med. 2003. PMID: 12817310 Review. German.
Cited by
-
Pentraxins, anti-pentraxin antibodies, and atherosclerosis.Clin Rev Allergy Immunol. 2009 Aug;37(1):36-43. doi: 10.1007/s12016-008-8098-6. Clin Rev Allergy Immunol. 2009. PMID: 19016000 Review.
-
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.PLoS Pathog. 2020 Mar 30;16(3):e1008340. doi: 10.1371/journal.ppat.1008340. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32226027 Free PMC article.
-
IgG4-related disease.Curr Opin Rheumatol. 2017 May;29(3):223-227. doi: 10.1097/BOR.0000000000000383. Curr Opin Rheumatol. 2017. PMID: 28319486 Free PMC article. Review.
-
Evaluation of the Risk of Getting Peripheral Artery Disease in Rheumatoid Arthritis and the Selection of Appropriate Diagnostic Methods.Cureus. 2020 Aug 16;12(8):e9782. doi: 10.7759/cureus.9782. Cureus. 2020. PMID: 32953298 Free PMC article. Review.
-
Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity.Arthritis Res Ther. 2013;15(6):R199. doi: 10.1186/ar4389. Arthritis Res Ther. 2013. PMID: 24267267 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials